Safety Reference
Danger
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
Sourcing Deucravacitinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Zinc(II) 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate
pharmaceutical intermediate
Sourcing Deucravacitinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Deucravacitinib is an oral selective tyrosine kinase 2 (TYK2) inhibitor that binds to the regulatory domain of TYK2, distinguishing it from other Janus kinase inhibitors. It is an active pharmaceutical ingredient used in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Deucravacitinib (CAS 1609392-27-9) is 2845.90.
2845.90
2845 90 10
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
BZZKEPGENYLQSC-FIBGUPNXSA-N
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4